Heart Disease Trials
Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.
Page 1 of 2 | Results 1 - 10 of 13
Neal Hadro, MD
Heart,
Surgery
Baystate Medical Center, 759 Chestnut St, Springfield, MA
The purpose of this study is to demonstrate that Fractional Flow Reserve (FFR)-guided Percutaneous Coronary Intervention (PCI) is non-inferior to coronary artery bypass graft surgery (CABG) in patients with multi-vessel Coronary Artery Disease (CAD). FFF-guided PCI might result in lower rates of death, heart attack, and the need for repeat revascularization as compared to what was seen after CABG surgery. There is also the possibility of a chance at a shorter recovery time with the minimally invasive FFR-guided PCI versus CABG surgery.
Dr. Amir Lotfi
Heart
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
Gregory Giugliano, MD
Heart
Baystate Medical Center, 759 Chestnut Street, Springfield, MA
Gregory Giugliano, MD
Heart
Baystate Medical Center, 759 Chestnut St, Springfield, MA
Abdallah Alameddine, MD
Heart,
Surgery
Baystate Medical Center, 759 Chestnut St, Springfield, MA
Abdallah Alameddine, MD
Heart,
Surgery
Baystate Medical Center, 759 Chestnut St, Springfield, MA
Hany Aziz, MD
Heart
Baystate Medical Center, 759 Chestnut St, Springfield, MA
Amir Lotfi, MD
Heart
Davis Family Heart & Vascular Center
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
The purpose of this study is to test the efficacy of 4 mg Pitavastatin daily on cardiovascular-related events among HIV-1 infected adults.
Daniel J. Skiest, MD
HIV,
Heart
Baystate Infectious Diseases Clinical Research
3300 Main Street
Springfield, MA 01199
Daniel Engelman, MD
Heart,
Surgery
Baystate Medical Center, 759 Chestnut St, Springfield, MA
Page 1 of 2 | Results 1 - 10 of 13